Therefore, this prospective observational study aimed to investigate the relationships between the CYP2D6 polymorphisms and plasma concentration of tamoxifen/endoxifen in Chinese patients with breast cancer treated with tamoxifen. This evidence concerns the gene CYP2D6 and breast cancer.